工信部：推进人工智能向医药全产业链深度赋能 依法依规引导企业有序竞争

Core Viewpoint - The Ministry of Industry and Information Technology emphasizes the need for high-quality development in the pharmaceutical industry, focusing on innovation, artificial intelligence integration, and enhanced intellectual property protection [1][2][3] Group 1: Meeting Overview - The meeting was chaired by Li Lecheng, Minister of Industry and Information Technology, to discuss the high-quality development of the pharmaceutical industry and to gather insights from industry leaders [2] - Ten pharmaceutical company representatives shared their experiences regarding drug research, smart manufacturing, innovation challenges, and intellectual property issues [2] Group 2: Key Initiatives and Focus Areas - The government aims to strengthen the pharmaceutical industry's innovation capabilities and ensure the industry can independently control its supply chain [3] - There is a strong emphasis on integrating artificial intelligence throughout the pharmaceutical value chain and enhancing the protection of intellectual property rights [3] - Companies are encouraged to promote entrepreneurial spirit, fulfill social responsibilities, and invest more in research and development [3]